entertainment -WSS

entertainment

author：hotspot 2025-09-28 02:30:02 - browse：88

Adobe

WASHINGTON — WuXi Biologics executives have joined the lobbying fray in the lead-up to a move by Congress to add the company to a blacklist meant to prevent certain biotech firms from doing business in the United States.

Legislation proposing that blacklist, known as the BIOSECURE Act, was passed in a 40-1 bipartisan vote on Wednesday by the House Oversight and Accountability Committee. That’s an important development because until now, the House Select Committee on the Chinese Communist Party had handled the bill in the House. That panel is an ad-hoc committee created to build bipartisan consensus on China policies, but it does not have the authority to pass legislation. A Senate committee also passed the BIOSECURE Act nearly unanimously earlier this year.

With the bill out of the Oversight Committee, the goal is for the House to pass it before the July 4 recess. That would set the legislation up to be included in a year-end must-pass legislative package, possibly the National Defense Authorization Act, which Congress has passed every year for decades.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： State of the Union pitch: Bigger Medicare drug price negotiations

hotspot

WSS

Target recalls 2.2 million additional candles due to laceration, burn hazards

Target recalls 2.2 million additional candles due to laceration, burn hazards

Target recalls 2.2 million additional candles due to laceration, burn hazards

Kim Kardashian sparks debate on benefits of full

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

focus

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

leisure time

Supreme Court strikes down use of affirmative action

Target recalls 2.2 million additional candles due to laceration, burn hazards

Guidelines to prevent youth baseball injuries need more muscle

Biden's 'march

Hollywood unions extend contract negotiations for actors

Maui funeral service workers on devastation of fires: 'I'm in shock'

How one medical school became remarkably diverse

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Streamlined flu vaccines recommended by FDA advisory panel

hotspot

Harvard's David Sinclair gets blowback over aging

Kim Kardashian sparks debate on benefits of full

Lack of health data on LGBTQ+ people has serious consequences

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

A new approach to psychiatric drug development

Large hospital system sues Multiplan for low

hotspot

hotspot

focus

explore